Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Appl Physiol Nutr Metab ; 32(6): 1148-55, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18059589

RESUMEN

Urate is a metabolic end product of purine metabolism that contributes about 66% of the antioxidant capacity of plasma. The objective of this study was to evaluate the importance of plasma urate as an antioxidant using pharmacological lowering and examining the impact on plasma antioxidant capacity and oxidative stress after intense exercise. Fifteen subjects ran for 45 min at approximately 80% VO2 max under the influence of probenecid (1 g/d) (PRO) or placebo (PLA) in a double-blind, crossover design. Blood samples obtained at baseline, pre-exercise, and immediately post-exercise were analyzed for F2-isoprostanes, lipid hydroperoxides (LHs), ferric-reducing ability of plasma (FRAP), urate, ascorbate (AA), and nitrite. A 2 (group)x2 (time) repeated-measures analysis of variance (ANOVA), one-way ANOVA, Tukey-Kramer multiple comparison tests, and Student's t tests were used for statistical analysis. PRO exhibited lowered urate and FRAP compared with baseline (p

Asunto(s)
Ejercicio Físico/fisiología , Estrés Oxidativo/fisiología , Probenecid/farmacología , Ácido Úrico/antagonistas & inhibidores , Ácido Úrico/sangre , Uricosúricos/farmacología , Adolescente , Adulto , Umbral Anaerobio/fisiología , Antioxidantes/metabolismo , Ácido Ascórbico/sangre , Composición Corporal/fisiología , Peso Corporal/fisiología , Compuestos Férricos , Humanos , Isoprostanos/sangre , Ácido Láctico/sangre , Peroxidación de Lípido/efectos de los fármacos , Masculino , Nitratos/sangre , Nitritos/sangre , Oxidación-Reducción
2.
J Appl Physiol (1985) ; 96(4): 1292-8, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-14672962

RESUMEN

Thirty strength-trained subjects were randomized to carbohydrate (CHO) or placebo (Pla) groups and lifted weights for 2 h (10 exercises, 4 sets each, 10 repetitions, with 2- to 3-min rest intervals). Subjects received 10 ml x kg(-1) x h(-1) CHO (6%) or Pla beverages during the weight training bout. Blood, saliva, and vastus lateralis muscle biopsy samples were collected before and after exercise. Blood cell counts were determined, and plasma was analyzed for IL-6, IL-10, IL-1 receptor antagonist (IL-1ra), IL-8, and cortisol. Muscle was analyzed for glycogen content and relative gene expression of 13 cytokines (IL-1alpha, IL-1beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p35, IL-12p40, IL-15, IFN-gamma, TNF-alpha) by use of real-time quantitative RT-PCR. Significant but modest increases were measured for plasma IL-6, IL-10, IL-1ra, and IL-8, but the pattern of increase did not differ between CHO and Pla groups. The rate of decrease in muscle glycogen content did not differ between CHO and Pla (P = 0.463). Muscle cytokine mRNA was detected preexercise for IL-1beta, IL-6, IL-15, IL-8, and TNF-alpha, and of these, IL-1beta, IL-6, IL-8, and TNF-alpha were significantly increased after the 2-h weight training bout. The increase in mRNA (fold difference from preexercise) did not differ between CHO and Pla groups. In summary, CHO vs. Pla ingestion did not alter modest increases measured for plasma IL-6, IL-10, IL-1ra, and IL-8, and muscle gene expression for IL-1beta, IL-6, IL-8, and TNF-alpha in strength-trained subjects lifting weights intensively for 2 h.


Asunto(s)
Carbohidratos/administración & dosificación , Sistema Inmunológico/efectos de los fármacos , Sistema Inmunológico/fisiología , Resistencia Física , Levantamiento de Peso/fisiología , Administración Oral , Adulto , Recuento de Células Sanguíneas , Citocinas/sangre , Citocinas/genética , Citocinas/metabolismo , Expresión Génica , Glucógeno/antagonistas & inhibidores , Humanos , Hidrocortisona/sangre , Masculino , Músculo Esquelético/metabolismo , ARN Mensajero/metabolismo , Factores de Tiempo
3.
Int J Sports Med ; 24(7): 541-7, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12968214

RESUMEN

Changes in immune and oxidative stress parameters were measured in ultramarathon runners competing in the 160-km Western States Endurance Run. Forty-five runners agreed to provide blood and saliva samples the morning before the race event, at the 90-km aid station, and 5 - 10 min post-race. Upper respiratory tract infection (URTI) during the two-week period post-race was assessed retrospectively by telephone interviews. Forty subjects completed 90-km (race time, 13.1 +/- 0.3 h), and 31 completed the 160-km race event (27.0 +/- 0.4 h). The blood neutrophil and monocyte counts rose 249 % and 214 %, respectively, in the 31 finishers. Salivary IgA (sIgA) secretion rate decreased significantly from 508 +/- 40 micro g/min pre-race, to 287 +/- 39 micro g/min at 90-km, and 254 +/- 30 micro g/min post-race (50 % decrease). Significant increases were measured in cytokines at 90-km and post-race, with post-race IL-10 increasing 9.5-fold, IL-1ra 6.1-fold, IL-6 50.2-fold, and IL-8 2.5-fold over pre-race levels. Post-race indicators of oxidative stress, F (2)-isoprostane and lipid hydroperoxides, increased 33 % and 88 %, respectively. Pearson product-moment correlations revealed positive correlations at 90-km between F (2)-isoprostane and IL-6 (r = 0.31, p = 0.048), IL-10 (r = 0.31, p = 0.050), and IL-8 (r = 0.43, p = 0.005), but no other significant relationships between immune and oxidative stress indicators at 90-km and post-race. In the group of runners completing at least 90 km of the race, 26 % reported an URTI episode during the two-week period post-race. A low sIgA secretion rate at 90-km was the best predictor of post-race URTI (173 +/- 34 micro g/min in those who later acquired URTI compared to 325 +/- 40 micro g/min in those without URTI, p = 0.007). In conclusion, a modest correlation was found between cytokines and F (2)-isoprostane at 90-km when the greatest oxidative stress occurred, but no other significant correlations in immune and oxidative stress indicators during and following a 160-km ultramarathon race event were noted. About one in four ultramarathoners reported URTI during the two-week period post-race, and a low sIgA secretion rate mid-race best predicted URTI occurrence.


Asunto(s)
Resistencia Física/inmunología , Resistencia Física/fisiología , Carrera/fisiología , Adulto , Citocinas/sangre , Femenino , Humanos , Peróxido de Hidrógeno/sangre , Inmunoglobulina A Secretora/análisis , Incidencia , Masculino , Persona de Mediana Edad , Estrés Oxidativo , Infecciones del Sistema Respiratorio/epidemiología , Saliva , Caracteres Sexuales
4.
J Appl Physiol (1985) ; 94(5): 1917-25, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12533503

RESUMEN

Sixteen experienced marathoners ran on treadmills for 3 h at approximately 70% maximal oxygen consumption (Vo(2 max)) on two occasions while receiving 1 l/h carbohydrate (CHO) or placebo (Pla) beverages. Blood and vastus lateralis muscle biopsy samples were collected before and after exercise. Plasma was analyzed for IL-6, IL-10, IL-1 receptor agonist (IL-1ra), IL-8, cortisol, glucose, and insulin. Muscle was analyzed for glycogen content and relative gene expression of 13 cytokines by using real-time quantitative RT-PCR. Plasma glucose and insulin were higher, and cortisol, IL-6, IL-10, and IL-1ra, but not IL-8, were significantly lower postexercise in CHO vs. Pla. Change in muscle glycogen content did not differ between CHO and Pla (P = 0.246). Muscle cytokine mRNA content was detected preexercise for seven cytokines in this order (highest to lowest): IL-15, TNF-alpha, IL-8, IL-1beta, IL-12p35, IL-6, and IFN-gamma. After subjects ran for 3 h, gene expression above prerun levels was measured for five of these cytokines: IL-1beta, IL-6, and IL-8 (large increases), and IL-10 and TNF-alpha (small increases). The increase in mRNA (fold difference from preexercise) was attenuated in CHO (15.9-fold) compared with Pla (35.2-fold) for IL-6 (P = 0.071) and IL-8 (CHO, 7.8-fold; Pla, 23.3-fold; P = 0.063). CHO compared with Pla beverage ingestion attenuates the increase in plasma IL-6, IL-10, and IL-1ra and gene expression for IL-6 and IL-8 in athletes running 3 h at 70% Vo(2 max) despite no differences in muscle glycogen content.


Asunto(s)
Citocinas/biosíntesis , Citocinas/sangre , Carbohidratos de la Dieta/farmacología , Músculo Esquelético/metabolismo , ARN Mensajero/biosíntesis , Carrera/fisiología , Adulto , Recuento de Células Sanguíneas , Glucemia/metabolismo , Citocinas/genética , ADN Complementario/biosíntesis , ADN Complementario/genética , Femenino , Expresión Génica , Glucógeno/metabolismo , Hormonas/sangre , Humanos , Hidrocortisona/sangre , Inmunoglobulina A/análisis , Inmunoglobulina A/metabolismo , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Músculo Esquelético/efectos de los fármacos , Consumo de Oxígeno/efectos de los fármacos , Consumo de Oxígeno/fisiología , ARN Mensajero/genética , Saliva/química , Saliva/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA